Related Experiment Video
Updated: Apr 6, 2026

09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.8K
Treatment of Recurrent Endometrial Carcinoma: Progress Toward a More Personalized Approach
Giorgio Bogani1, Valentina Chiappa2, Domenica Lorusso2
1National Cancer Institute, Milan, Italy giorgiobogani@yahoo.it.
Abstract
No abstract available in PubMed .
Related Concept Videos
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers
1.5K
1.5K

